Shira Orr

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

Myrna Nahas, Dina Stroopinsky, Jacalyn Rosenblatt et al. · British Journal of Haematology · 2019 · 72 citations · Full text

Cancer Immunosurveillance, Allergy, Immune Microenvironment +13

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model

Dina Stroopinsky, Jessica Liegel, Manoj Bhasin et al. · Haematologica · 2021 · 30 citations · Full text

TGF-β affinity-bound to a macroporous alginate scaffold generates local and peripheral immunotolerant responses and improves allocell transplantation

Shira Orr, Itai Strominger, Ekaterina Eremenko et al. · Acta Biomaterialia · 2016 · 23 citations

Regenerative Medicine, Tissue Engineering, Cell Therapy +15

<scp>MUC</scp>1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism

Dina Stroopinsky, Hasan Rajabi, Myrna Nahas et al. · Journal of Cellular and Molecular Medicine · 2018 · 15 citations · Full text

Survivin‐mediated Mechanism, Mixed-phenotype Acute Leukemia, Immunology +16

Personalized tumor vaccine for pancreatic cancer

Shira Orr, Ling Huang, James Moser et al. · Cancer Immunology Immunotherapy · 2022 · 14 citations · Full text

Vaccination, Tumor Immunology, Pancreatic Cancer +4